UC Irvine is a world leader in the development and application of advanced imaging technologies. Researchers in this field are developing technologies to permit better evaluation of breast tissue for the detection of tumors and determination of response to treatment. This later objective will lead to minimizing the toxicity experienced by our breast cancer patients and provide direction for clinical treatment planning.
- Albert Cerussi, PhD
Dr. Cerussi is involved in the development and testing of new advanced optical imaging technologies that use light instead of X-rays and their applications to the detection and monitoring of therapy in breast cancer. These include Broadband Diffuse Optical Spectroscopy (DOS). Dr. Cerussi works in the Beckman Laser Institute and Medical Clinic.
- Dr. Gultekin Gulsen, PhD
Dr. Gulsen is focused on integrating Near-Infrared Tissue Spectroscopy and MRI to provide simultaneous sets of data to increase the range of information obtained and to more accurately evaluate the biological functions of the tissues being examined, such a breast cancer.
- David Hsiang, MD
Dr. Hsiang is a breast health care physician and scientist who is focused on the evaluation of advanced imaging techniques, specifically diffuse optical spectroscopy, as a method for detecting breast cancer and for quickly determining if a patient is benefiting from the chosen therapy.
- Orhan Nalcioglu, PhD
Dr. Nalcioglu is director of the John Tu & Thomas Yuen Center for Functional Onco-Imaging (CFOI). He has a general research interest in image-based measurement techniques for biomedical research. Dr Nalcioglu works with Drs Lydia Su and Gultekin Gulsen in the development of MRI based advanced imaging technologies for breast cancer.
- Min-Ying (Lydia) Su, PhD
Dr. Su directs the development of advanced MRI breast cancer imaging technologies. Dr. Su's earlier technological advances have already been translated into clinical studies. She continues to design more advanced imaging techniques within the John Tu & Thomas Yuen Center for Functional Onco-Imaging (CFOI).
- Bruce Tromberg, PhD
Dr. Tromberg is the Director of the Beckman Laser Institute and Medical Clinic and Lead investigator of the NCI funded Network for Translational Research: Optical Imaging (NTROI). In the context of these organizations, Dr Tromberg is involved in the development of multiple different advanced optical imaging technologies for breast cancer.
>> Link back to "Laboratory Research"